Dr. Eric Verdin, MD is the president and CEO of the Buck Institute for Research on Aging in Novato, California. He is also a medical professor at the University of California, San Francisco. Dr. Verdin’s lab investigates the connection between aging and the immune system. Dr. Verdin earned his MD at the University of Liege and went on to finish clinical and research training at Harvard Medical School. He has held posts on the faculties of the University of Brussels, the National Institutes of Health (NIH), and the Picower Institute for Medical Research. Dr. Verdin is also a medical professor at the University of California, San Francisco.
Dr. Verdin has authored over 210 scientific articles and possesses over 15 patents. His team investigates how metabolism, food, and tiny chemicals influence the activity of enzymes and sirtuins, and hence the aging process. Dr. Verdin’s research focuses on age-related disorders such as Alzheimer’s.
Dr. Verdin joined the Buck Institute in 2016 following 20 years as a senior investigator at the Gladstone Institutes, where he also served as associate director from 2004 to 2016.Dr. Verdin also serves on the National Institute on Drug Abuse‘s advisory committee.
Read more about Dr. Eric Verdin here.
Inspiring Talks by Dr. Eric Verdin
- “Science is showing that while chronological aging is inevitable, biological aging is malleable. There’s a part of it that you can fight, and we are getting closer and closer to winning that fight.”
- “How many other viruses are associated with other human autoimmune diseases: type 1 diabetes, Rheumatoid Arthritis, Crohn’s, Ulcerative colitis ….?”
- “Longitudinal analysis reveals high prevalence of Epstein-Barr virus-associated with multiple sclerosis”
- “A new era of healthy aging is possible if we work together and let science lead.”
- “We exist to solve the problem of accelerated ovarian aging. It is our mission to change the trajectory of women’s health.”
- “The race for reprogramming in aging is on: Altos Labs (Milner), Retro Biosciences, Turn Bio, Shift Bioscience, NewLimit. Overhyped or real promise??”
- “We need to address this as a community and demand from NIH that they change this embarrassing statistic if we want the academic enterprise to survive. The average age for a first RO1 should be 32, not 44!!”
- “Regular physical activity is the most potent medicine we have today against aging!!! Use it abundantly while we are developing better alternatives.”
- “Bay Area researchers are spending millions of dollars to see if they can actually stop the aging process. KPIX 5’s John Ramos asks Bucks Institute CEO Dr. Eric Verdin what they’re doing to try to keep people forever young.”
- “How to face-lift to a geriatric social network: create a creepy Metaverse. Has Zuckerberg not learned what 18 months of Zoom calls have done to our collective psyche? We need real human interactions to be happy.”